Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

IMSG nanoparticles improve vaccine delivery and immune response through hair follicles.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

Semaglutide helps obese PCOS patients lose weight and improve health.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

A patient developed a blister at the injection site after hepatitis C treatment.

Abatacept may help some people with alopecia areata regrow hair.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

BMS-470539 reduces skin fibrosis and inflammation.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

Tofacitinib may help regrow hair in alopecia areata patients.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Rheumatology clinics should always provide preconception counseling for women on DMARDs.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

Higher monocyte counts predict less effective adalimumab treatment in hidradenitis suppurativa patients.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

A woman with severe angioedema improved significantly after treatment with rituximab.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.